Меню
Идёт набор NCT07649356

Significance of Estrogen Status for Muscle Function, Physical Fitness, and Physiological Health Parameters - a Comparison of Age-matched Groups of Women Before and After Menopause.

Наблюдательное Muscle Mass and Strength Menopause

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Muscle Mass and Strength, Menopause. Базовые параметры: от 47 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Дания
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effects of Estrogen on Muscle Gain During 12-weeks of Exercise in Post-menopausal Women

Обзор

As females age and transition through menopause, the decline in oestrogen level profoundly affects skeletal muscle mass and function. HER-MUSCLE aims to unravel the differences in pre and post menopausal women, in regards to muscle size, strength and function. Focusing on postmenopausal females, an increasingly at-risk demographic, HER-MUSCLE addresses a critical gap in understanding how oestrogen influences muscle mass and function. The project involves: 1. Molecular Analysis: Advanced techniques will study the muscle microenvironment, focusing on muscle stem cells (MuSCs), fibro-adipogenic progenitors (FAPs), and other cells critical for muscle regeneration and maintenance. 2. Mitochondrial Function assessed in vivo via magnetic resonance spectroscopy: The impact of oestrogen on mitochondrial health will be examined, exploring how it preserves mitochondrial function and ability to recovery and resist fatigue in response to muscle contractions. Our preliminary data indicate that oestrogen can promote muscle protein synthesis. HER-MUSCLE aims to pave the way for novel therapeutic strategies to manage sarcopenia in postmenopausal women, ultimately leading to better health outcomes and enhanced well-being for this growing population segment.

Подробное описание

As females age and transition through menopause, the decline in oestrogen level profoundly affects skeletal muscle mass and function. HER-MUSCLE aims to unravel the differences in pre and post menopausal women, in regards to muscle size, strength and function.

Focusing on postmenopausal females, an increasingly at-risk demographic, HER-MUSCLE addresses a critical gap in understanding how oestrogen influences muscle mass and function.

The project involves:

1. Molecular Analysis: Advanced techniques will study the muscle microenvironment, focusing on muscle stem cells (MuSCs), fibro-adipogenic progenitors (FAPs), and other cells critical for muscle regeneration and maintenance. 2. Mitochondrial Function assessed in vivo via magnetic resonance spectroscopy: The impact of oestrogen on mitochondrial health will be examined, exploring how it preserves mitochondrial function and ability to recovery and resist fatigue in response to muscle contractions.

Our preliminary data indicate that oestrogen can promote muscle protein synthesis. HER-MUSCLE aims to pave the way for novel therapeutic strategies to manage sarcopenia in postmenopausal women, ultimately leading to better health outcomes and enhanced well-being for this growing population segment.

Первичные конечные точки

  • Muscle mass [Срок оценки: 1 week]
Вторичные конечные точки (12)
  • Mitochondria Function in vivo measured as phosphocreatine recovery rate [Срок оценки: 1 weeks]
  • Mitochondria Function in vitro measured as maximal oxygen consumption [Срок оценки: 1 weeks]
  • Body composition [Срок оценки: 1 weeks]
  • Satelitte cells [Срок оценки: 1 weeks]
  • Muscle fiber cross-sectional Area [Срок оценки: 1 weeks]
  • Expression of Muscle proteins [Срок оценки: 1 weeks]
  • FACS Analysis [Срок оценки: 1 weeks]
  • Muscle Strength [Срок оценки: 1 weeks]
  • Functional tests [Срок оценки: 1 weeks]
  • Cardiovascular fitness [Срок оценки: 1 week]
  • Maximal fat oxidation rate [Срок оценки: 1 week]
  • Resisting metabolic rate [Срок оценки: 1 week]

Критерии участия

Критерии включения

  • Regular menstrual bleeding (21-35 days cycle).
  • At least 9 menstrual cycles the last year
  • Age >47 years old
  • BMI 20-30

Критерии исключения

  • Only premenopausal women: Follicular stimulating hormone > 30 mmol/L
  • Systematic strength training during the last year (> 1 strength training session per week)
  • Systematic high intensity cardiovascular training during the last year (<2 times per week)
  • Injuries to the legs which may prevent participation in the physical training program
  • Magnetizable metals or electrical devices implanted in the body, such as a pacemaker
  • Use of medication that can influence the effect of immobilization and/or training
  • Muscular or joint disorders which may affect the results
  • Metabolic diseases (such as diabetes and cardiovascular diseases)
  • Previous or present liver or cancer disease
  • Current or previous thrombosis
  • Porphyria
  • Epilepsia
  • Systemic autoimmune disease
  • Edema
  • Smoking or use of other nicotine containing products
  • Claustrophobia
  • Addictive behavior, defined as abuse of cannabis, opioids, or other intoxicating substances.
  • Lack of ability to cooperate
  • Blood parameters out of normal range at the health check
  • Blood pressure above 140/90 mmHg

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Модель наблюдения
Другое

Центры проведения

Дания · 1 центр
  • Aarhus University — Aarhus

Идентификаторы

NCT: NCT07649356 · E30 HER-MUSCLE cross sectional

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗